You have searched for "trial"
Showing 1-10 of 1841
PETALING JAYA: The efficacy of a potential Covid-19 vaccine continues to be a concern even as the need for it becomes prevalent.
RISK aversion dominated globally due to rising coronavirus cases as well as dwindling prospects of US fiscal aid before the US elections. This led investors to flock to the safe-haven dollar – sending the dollar index to a nearly two-week high, up 0.86% to 93.86.
NEW YORK/LONDON: Global shares closed lower on Thursday as investors shied from risk and sought safe havens such as the U.S. dollar on fears that a resurgence in coronavirus cases and a lack of more U.S. fiscal stimulus would hobble the world economy.
BENGALURU: South Korean, Indian and Thai shares led declines in Asia on Wednesday, as a halt in more COVID-19 vaccine trials and concerns over China's property sector added to potential headwinds for the region's emerging markets.
KUALA LUMPUR: Glove counters advanced on Wednesday amid news that Johnson & Johnson's Covid-19 vaccine trial has been halted due a safety concern.
NEW YORK: Wall Street lost ground on Tuesday, with halted COVID-19 vaccine trials and an elusive U.S. stimulus agreement weighing on sentiment as third quarter earnings season got underway.
SMALL and medium enterprises (SMEs), some of which may run out of cash flow by end of this month, are looking for a plan by the government to boost sales and revenue.
WASHINGTON: The U.S. government has awarded $486 million to AstraZeneca Plc to develop and secure supplies of up to 100,000 doses of COVID-19 antibody treatment, a similar class of drug that was used in treating President Donald Trump.